Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Breast”

481 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 481 results

Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT05960201
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Who this might be right for
Carcinoma, Lobular
Asan Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Large-scale testing (Phase 3)Study completedNCT00002967
What this trial is testing

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Large-scale testing (Phase 3)Looking for participantsNCT04722692
What this trial is testing

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Who this might be right for
DCISBreast CancerBreast Neoplasms+1 more
Uppsala University 500
Not applicableUnknownNCT00470236
What this trial is testing

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

Who this might be right for
Carcinoma, Ductal, Breast
Trans Tasman Radiation Oncology Group 1,608
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)Ended earlyNCT00110136
What this trial is testing

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

Who this might be right for
Breast CancerHot Flashes
Wake Forest University Health Sciences 9
Not applicableStudy completedNCT03375892
What this trial is testing

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Medical College of Wisconsin 11
Not applicableUnknownNCT00536718
What this trial is testing

Genetics of Women With Lobular Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
National Cancer Research Network 3,000
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Large-scale testing (Phase 3)Active Not RecruitingNCT00310180
What this trial is testing

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Who this might be right for
Breast AdenocarcinomaHormone Receptor PositiveStage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 10,273
Large-scale testing (Phase 3)Active Not RecruitingNCT02115282
What this trial is testing

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+4 more
National Cancer Institute (NCI) 608
Testing effectiveness (Phase 2)Study completedNCT02150525
What this trial is testing

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Who this might be right for
Ductal Breast Carcinoma in SituBreast Cancer, Stage IBreast Cancer, Stage II+1 more
Ohio State University Comprehensive Cancer Center 52
Not applicableActive Not RecruitingNCT04916808
What this trial is testing

The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing

Who this might be right for
DCIS
PreludeDx 1,500
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Early research (Phase 1)Study completedNCT00003002
What this trial is testing

HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer

Who this might be right for
Breast CancerLung CancerOvarian Cancer
University of Washington 60
Large-scale testing (Phase 3)Study completedNCT00003857
What this trial is testing

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 636
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Load More Results